![]() |
市場調查報告書
商品編碼
1872749
冷雷射治療市場規模及預測(2021-2031年),全球及區域佔有率、趨勢及成長機會分析報告涵蓋範圍:按產品、應用、最終用戶分類Cold Laser Therapy Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User |
||||||
2024年冷雷射治療市場規模為3.5633億美元,到2031年將達到5.6262億美元;預計2025-2031年期間的複合年成長率將達到6.90%。
推動市場成長的關鍵因素包括慢性疼痛疾病(例如骨科疾病)的日益普遍,以及冷雷射在皮膚科的應用,這些因素共同促進了冷雷射療法市場的成長。然而,高昂的治療費用阻礙了市場的成長。
冷雷射治療市場的市場促進因素
冷雷射療法在多個醫療領域有廣泛的應用,涵蓋疼痛管理、骨科、皮膚科和牙科等。由於關節炎、肌肉骨骼損傷、神經性疼痛和慢性損傷等骨科疾病的盛行率不斷上升,醫療機構和家庭護理中冷雷射療法的應用也日益增加。世界衛生組織(WHO)發布的資料顯示,截至2021年2月,全球約有17.1億人患有肌肉骨骼疾病,其中腰痛是最常見的肌肉骨骼疾病,影響全球5.68億人。冷雷射療法是一種非侵入性且有效的治療方法,可以緩解慢性下背痛。 Hindawi於2022年2月發表了一項題為「低強度雷射療法治療椎間盤源性腰椎神經根病變患者的療效」的研究,該研究納入了110名患有急性腰痛和單側椎間盤源性腰椎神經根病變的患者。在所有患者中,55例接受了低強度雷射療法(LLLT)合併常規物理治療,另55例患者作為對照組,僅接受了常規物理治療。研究表明,在治療椎間盤源性腰椎神經根病變方面,與單獨使用常規物理治療相比,LLLT作為常規物理治療的輔助療法,能夠顯著改善局部軀幹活動度、疼痛強度及相關功能障礙。
此外,冷雷射療法在皮膚科和美容醫學領域被廣泛用於非侵入性皮膚再生、抗衰老治療和改善膚質。低強度雷射療法(LLLT)最成功的商業應用是治療男性和女性的雄性禿(AGA)。 Springer Link 於 2022 年 2 月發表了一項題為「低強度雷射療法治療雄性禿的療效評估」的研究,該研究使用了經美國食品藥物管理局(FDA)批准的 iHelmet(深圳思力科技有限公司)治療 1383 名患者。研究表明,LLLT 頭盔治療對 51.9% 的輕度 AGA 患者和 57.4% 的中重度 AGA 患者俱有中等程度的療效。因此,上述因素促使冷雷射設備作為一種治療手段在現代醫療保健領域中越來越廣泛的應用,並推動了冷雷射療法市場的成長。
冷雷射治療市場:細分市場概覽
依產品分類,冷雷射治療市場分為儀器和配件兩大類。 2024年,儀器類產品佔據了冷雷射治療市場更大的佔有率,預計在2024年至2031年期間將維持較高的複合年成長率。
依應用領域分類,冷雷射治療市場可分為骨科、皮膚科、神經科和其他領域。預計到2024年,骨科領域將佔據最大的市場。
依最終用戶分類,市場可分為醫院、專科診所、家庭護理機構和其他機構。 2022年,醫院佔據了最大的市場。預計在2024年至2031年期間,專科診所的複合年成長率將最高。專科診所通常專注於某些特定疾病,例如疼痛治療、運動傷害、物理治療、皮膚科或牙科,而這些領域正是冷雷射療法的重要應用領域。這種方法使診所能夠利用冷雷射設備提供更好的治療效果並累積更豐富的專業知識,從而提高患者的滿意度和信任度。在專科診所中,冷雷射療法通常與物理治療、脊椎矯正、針灸或皮膚護理療程相結合。除了提高治療效果外,這種互補策略也有助於診所區別於一般醫院。
冷雷射治療市場:地域概覽
根據地理位置,市場可分為北美、亞太、歐洲、中東和非洲以及南美和中美洲。就收入而言,北美在2024年佔據冷雷射治療市場的主導地位。預計亞太地區在預測期內將實現冷雷射治療市場最快的複合年成長率。
2022年,北美佔據全球最大的市場佔有率,預計從2022年到2030年將繼續保持領先地位。 2022年,美國在北美地區市佔率最大,其次是加拿大。根據美國疾病預防與健康促進辦公室預測,由於人口老化和肥胖等其他人口趨勢,到2040年,關節炎患者人數預計將上升至7,840萬人。美國骨科疾病和肌肉骨骼損傷的盛行率很高,這擴大了該地區冷雷射療法的市場佔有率。根據《加拿大健康科技雜誌》報道,2022年,加拿大約有800萬人患有慢性疼痛,80%的成年人一生中至少經歷過一次慢性下背痛。這些人每天都面臨著影響其社交、身體、心理和職業等方面的各種挑戰。 2024-2031 年間,Erchonia FX 635 等創新冷雷射設備的普及、完善的醫療保健基礎設施以及先進雷射治療技術的日益普及,預計將推動區域市場成長。
The cold laser therapy market size was valued at US$ 356.33 million in 2024 to US$ 562.62 million by 2031; it is anticipated to record a CAGR of 6.90% during 2025-2031.
Key factor driving the market growth are the growing prevalence of chronic pain conditions such as orthopedic disorders and utilization of cold laser in dermatology propel the cold laser therapy market growth. However, high treatment costs hamper the growth of the market.
Market Drivers of the Cold Laser Therapy Market
Cold laser therapy has diverse applications across multiple healthcare domains, spanning pain management, orthopedics, dermatology, and dentistry. Due to the rising prevalence of orthopedic conditions such as arthritis, musculoskeletal injuries, neuropathic pain, and chronic injuries, the utilization of cold laser therapy in healthcare institutions and homecare settings has increased. According to the data published by the World Health Organization (WHO), in February 2021, ~1.71 billion individuals worldwide suffered from musculoskeletal problems, with lower back pain being the most widespread musculoskeletal condition, affecting 568 million people globally. Cold laser therapy is a noninvasive and effective treatment to alleviate chronic back pain. A study, "Effectiveness of Low-Level Laser Therapy in Patients with Discogenic Lumbar Radiculopathy," published by Hindawi in February 2022, was carried out with 110 patients suffering from acute lower back pain and unilateral discogenic lumbar radiculopathy. Of the total patients, 55 patients were treated with LLLT combined with conventional physical therapy, while the other control group of 55 patients was treated with only conventional physical therapy. The study demonstrated that LLLT, as an adjunct therapy to conventional physical therapy, significantly improved local trunk movements, pain intensity, and related functional disability, as compared with conventional physical therapy alone in the treatment of discogenic lumbar radiculopathy.
Additionally, cold laser therapy is employed in dermatology and aesthetic medicine for noninvasive skin rejuvenation, anti-aging treatment, and improvement of skin texture. The most successful commercial use of LLLT is in managing androgenetic alopecia (AGA) for both men and women. A study, "Efficacy Assessment for Low-Level Laser Therapy in the Treatment of Androgenetic Alopecia," published by Springer Link in February 2022, was carried out on 1,383 patients using Food and Drug Administration (FDA)-cleared iHelmet (Slinph Technologies Co., Ltd, Shenzhen, China). The study showed that treatment with LLLT helmets was moderately effective for 51.9% of users with mild AGA and 57.4% with moderate-to-severe AGA. Therefore, the abovementioned factors contribute to the growing utilization of cold laser devices as a therapeutic modality in modern healthcare settings and are responsible for the cold laser therapy market growth.
Cold Laser Therapy Market: Segmental Overview
The cold laser therapy market, by product, is segmented into instruments and accessories. The instruments segment held the larger cold laser therapy market share in 2024 and is anticipated to register the higher CAGR during 2024-2031.
The cold laser therapy market, by application, is segmented into orthopedics, dermatology, neurology and others. The orthopedics segment is expected to hold the largest market share in 2024.
The market, by end user, is segmented into hospitals, specialty clinics, homecare settings, and others. In 2022, the hospital segment held the largest share of the market The specialty clinics segment is anticipated to register the highest CAGR during 2024-2031. Specialty clinics frequently concentrate on certain ailments, such as pain treatment, sports injuries, physiotherapy, dermatology, or dentistry, all of which are important fields in which cold laser therapy finds use. This approach increases patient happiness and trust by enabling clinics to use cold laser equipment to provide better results and develop deeper expertise. Cold laser therapy is frequently combined with physiotherapy, chiropractic adjustments, acupuncture, or skincare procedures in specialty clinics. In addition to improving therapeutic effectiveness, this complementary strategy aids clinics in setting themselves apart from regular hospitals.
Cold Laser Therapy Market: Geographical Overview
Based on geography, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, North America dominated the cold laser therapy market share in 2024. Asia Pacific is expected to register the fastest CAGR in the cold laser therapy market during the forecast period.
In 2022, North America held the largest global market share and is estimated to continue its dominance from 2022 to 2030. The US held the largest market share in the region in 2022, followed by Canada. According to by US Office of Disease Prevention and Health Promotion, the prevalence of arthritis is expected to rise to 78.4 million by 2040 due to aging and other population trends such as obesity. The US has a high prevalence of orthopedic diseases and musculoskeletal injuries, which expand the cold laser therapy market share in the region. According to the Canadian Journal of Health Technologies, in 2022, ~8 million people in Canada live with chronic pain and 80% of adults experience chronic low back pain at least once during their lifetime. These individuals face various challenges impacting their social, physical, mental, and professional aspects on a daily basis. The availability of innovative cold laser devices such as Erchonia FX 635, well-developed healthcare infrastructure, and the rising adoption of advanced laser therapy technologies are expected to fuel the regional market growth during 2024-2031.